Advinus offers heterotopic (subcutaneous) xenograft models in immuno-deficient mice. Xenograft models of human cancer play an important role in the screening and evaluation of candidates for new anticancer agents. These models are derived from human tumor cell lines. For more details visit: PD Efficacy Models Oncology.
A range of animal models of Fibrosis are on offer for screening anti-fibrotic activity. Advinus has experience in running multiple drug discovery programs from hit identification to clinical candidate identification in the area of fibrosis. Fibrosis is often defined as a wound-healing response that has gone out of control. For more details about services offered, please visit: PD Efficacy Models Other Therapeutic Areas.